2009Jiangsu Medical JournalRequires access

Clinical analysis of secondary drug resistance in patients with retreated pulmonary tuberculosis

Fa Zhang

Open publisher page 0 citations

Abstract

Objective To investigate the features of drug resistance in the patients with retreated pulmonary tuberculosis with common antituberculotics. Methods The sensibility of tubercule bacillus to the antituberculotics was tested in 285 patients with retreated pulmonary tuberculosis.Results Of 285 patients,118 cases(41.4%) had a drug resistance to isoniazid,71 cases(24.9%) had a drug resistance to rifampicinthe,134 cases(47.0%) had a drug resistance to streptomycin,62 cases(21.8%) had a drug resistance to pyrazinamide,87 cases(30.5%) had a drug resistance to ethambutol.The percentage of having drug resistance to 2 to 3 first-line antituberculotics was more than that to 4 to 5 drugs resistance (60.3% vs.19.7%)(P0.01).Conclusion The patients with retreated pulmonary tuberculosis are easy to produce drug resistance to the first-line antituberculotics and commonly need a combined use of the second-line antituberculotics.

About this research paper

What this paper is about

Objective To investigate the features of drug resistance in the patients with retreated pulmonary tuberculosis with common antituberculotics. Methods The sensibility of tubercule bacillus to the antituberculotics was tested in 285 patients with retreated pulmonary tuberculosis.Results Of 285 patients,118 cases(41.4%) had a drug resistance to isoniazid,71 cases(24.9%) had a drug resistance to rifampicinthe,134 cases(47.0%) had a drug resistance to streptomycin,62 cases(21.8%) had a drug resistance to pyrazinamide,87 cases(30.5%) had a drug resistance to ethambutol.The percentage of having drug resistance to 2 to 3 first-line antituberculotics was more than that to 4 to 5 drugs resistance (60.3% vs.19.7%)(P0.01).Conclusion The patients with retreated pulmonary tuberculosis are easy to produce drug resistance to the first-line antituberculotics and commonly need a combined use of the second-line antituberculotics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the features of drug resistance in the patients with retreated pulmonary tuberculosis with common antituberculotics. Methods The sensibility of tubercule bacillus to the antituberculotics was tested in 285 patients with retreated pulmonary tuberculosis.Results Of 285 patients,118 cases(41.4%) had a drug resistance to isoniazid,71 cases(24.9%) had a drug resistance to rifampicinthe,134 cases(47.0%) had a drug resistance to streptomycin,62 cases(21.8%) had a drug resistance to pyrazinamide,87 cases(30.5%) had a drug resistance to ethambutol.The percentage of having drug resistance to 2 to 3 first-line antituberculotics was more than that to 4 to 5 drugs resistance (60.3% vs.19.7%)(P0.01).Conclusion The patients with retreated pulmonary tuberculosis are easy to produce drug resistance to the first-line antituberculotics and commonly need a combined use of the second-line antituberculotics.

Key concepts: Ethambutol, Medicine, Drug resistance, Pyrazinamide, Streptomycin, Drug, Isoniazid, Tuberculosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical analysis of secondary drug resistance in patients with retreated pulmonary tuberculosis — Research Paper | ScholarLens